The diagnosis and classification of polymyositis

Journal of Autoimmunity

Volumn 48-49, Issue , 2014, Pages 118-121

  Milisenda, J C ^a,b   Selva O'Callaghan, A ^c   Grau, J M ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Idiopathic inflammatory myopathies; Polymyositis

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; CLASSIFICATION ALGORITHM; CLINICAL FEATURE; DIAGNOSIS; DIAGNOSTIC ALGORITHM; DISEASE CLASSIFICATION; ELECTROMYOGRAPHY; EXTRAMUSCULAR MANIFESTATION; GASTROINTESTINAL SYMPTOM; HUMAN; HUMORAL IMMUNITY; IMMMUNOPATHOGENESIS; LUNG DISEASE; MUSCLE BIOPSY; MUSCLE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; SEROLOGY;

IDIOPATHIC INFLAMMATORY MYOPATHIES; POLYMYOSITIS;

ACUTE DISEASE; AUTOANTIBODIES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; MACROPHAGES; POLYMYOSITIS;

EID: 84895871171     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.025     Document Type: Article

References (27)

1. Bohan A., Peter J.B. Polymyositis and dermatomyositis (first of two parts). NEngl J Med 1975, 292:344-347.
2. Bohan A., Peter J.B. Polymyositis and dermatomyositis (second of two parts). NEngl J Med 1975, 292:403-407.
3. Arahata K., Engel A.G. Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984, 16:193-208.
4. Dalakas M.C. Polymyositis, dermatomyositis and inclusion-body myositis. NEngl J Med 1991, 325:1487-1498.
5. Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003, 362:971-982.
6. Milisenda J.C., Prieto-González S., Grau J.M. Miositis con cuerpos de inclusión (forma esporádica). Semin la Fund Española Reumatol 2012, 13:23-30.
7. Benveniste O., Leger J.M. Inflammatory or necrotizing myopathies, myositides and other acquired myopathies, new insight in 2011. Presse Med 2011, 40:197-198.
8. Cox S., Limaye V., Hill C., Blumbergs P., Roberts-Thomson P. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 2010, 13:117-124.
9. Khan S., Christopher-Stine L. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features. Rheum Dis Clin North Am 2011, 37:143-158.
10. Selva O'Callaghan A., Trallero Araguas E. Inflammatory myopathies. Dermatomyositis, polymyositis, and inclusion body myositis. Reumatol Clin 2008, 4:197-206.
11. Prieto S., Grau J.M. The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 2010, 9:330-334.
12. Andras C., Ponyi A., Constantin T., Csiki Z., Szekanecz E., Szodoray P., et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. JRheumatol 2008, 35:438-444.
13. Ungprasert P., Leeaphorn N., Hosiriluck N., Chaiwatcharayut W., Ammannagari N., Raddatz D.A. Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in asian population. ISRN Rheumatol 2013, 2013. ID:509354.
14. Selva-O'Callaghan A., Grau J.M., Gámez C., Vidaller A., Martinez X., Trallero E., et al. Conventional cancer screening versus PET/TC in dermatomyositis/polymyositis. Am J Med 2010, 123:558-562.
15. Nagaraju K., Lundberg I.E. Polymyositis and dermatomyositis: pathophysiology. Rheum Dis Clin North Am 2011, 37:159-171.
16. Fernandez C., Bardin N., De Paula A.M., Salort-Campana E., Benyamine A., Franques J., et al. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis. Med Baltim 2013, 92:15-24.
17. Labirua A., Lundberg I.E. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol 2010, 22:633-638.
18. Dalakas M.C. Pathophysiology of inflammatory and autoimmune myopathies. Presse Med 2011, 40:237-247.
19. Goebels N., Michaelis D., Engelhardt M., Huber S., Bender A., Pongratz D., et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. JClin Invest 1996, 97:2905-2910.
20. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002, 8:379-385.
21. Harris-Love M.O., Shrader J.A., Koziol D., Pahlajani N., Jain M., Smith M., et al. Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatol Oxf 2009, 48:134-139.
22. Spiera R., Kagen L. Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol 1998, 10:556-561.
23. Fathi M., Lundberg I.E., Tornling G. Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med 2007, 28:451-458.
24. Fathi M., Vikgren J., Boijsen M., Tylen U., Jorfeldt L., Tornling G., et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 2008, 59:677-685.
25. Goodwin D.W. Imaging of skeletal muscle. Rheum Dis Clin North Am 2011, 37:245-251.
26. Iaccarino L., Gatto M., Bettio S., Caso F., Rampudda M., Zen M., et al. Overlap connective tissue disease syndromes. Autoimmun Rev 2013, 12:363-373.
27. Chang C. Neonatal autoimmune diseases: a critical review. JAutoimmun 2012, 38:J223-J238.